Investor Information: Corporate Profile

PhotoMedex is a global skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. The company provides proprietary products and services that address skin diseases and conditions including psoriasis, vitiligo, acne, actinic keratosis (a precursor to certain types of skin cancer) and photo damage. Its experience in the physician market provides the platform to expand its skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. As a result of its December 2011 merger with Radiancy Inc., PhotoMedex has added a range of home-use devices under the no!no!™ brand, for various indications including hair removal, acne treatment and skin rejuvenation. The company also offers a professional product line for acne clearance, skin tightening, psoriasis care and hair removal sold to physician clinics and spas.

Featured Report
Download Documentation Investor Presentation - Acquisition. LCA-Vision
Download Documentation Finalists - Retail and Consumer Products
Download Documentation Fastest Growing Public Companies
Recent NewsMore >>
06/23/15PhotoMedex Reports Strong no!no!™ Sales During Recent Home Shopping Events, Exceeding Unit Sales Goal
HORSHAM, Pa.--(BUSINESS WIRE)--Jun. 23, 2015-- PhotoMedex, Inc. (NasdaqGS and TASE:PHMD) announces two very successful live television home shopping sales events, one in the U.S. at the end of May and the other in the UK at mid-June. Consumers purchased approximately 17,400 units of no!no!™ Hair and retail sales of nearly $3.5 million in a 24-hour period in the U.S. The company’s unit sales exceeded its pre-event expectations, and also exceeded a similar... 
06/23/15PhotoMedex Sells XTRAC® Business to MELA Sciences for $42.5 Million, Pays off All Outstanding Debt
HORSHAM, Pa.--(BUSINESS WIRE)--Jun. 23, 2015-- PhotoMedex, Inc. (NasdaqGS and TASE:PHMD) announces the sale of its worldwide XTRAC® and VTRAC® psoriasis and vitiligo treatment businesses to MELA Sciences, Inc. (Nasdaq:MELA) for $42.5 million in cash. In addition, the company announces it has paid off in full all outstanding debt, which totaled $40.1 million as of June 22, 2015. “PhotoMedex is now able to focus solely on our core consumer and ... 
05/11/15PhotoMedex Reports First Quarter Financial Results
HORSHAM, Pa.--(BUSINESS WIRE)--May 11, 2015-- PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) reports financial results for the three months ended March 31, 2015. Financial highlights of the first quarter of 2015 include the following (all comparisons are with the first quarter of 2014 and all figures quoted are GAAP, unless stated otherwise): Revenues of $28.1 million, a decrease of 44% Gross profit of $20.2... 
04/07/15PhotoMedex Announces the Return of the no!no! Brand to Japan via Synergy Trading Corporation
Leading consumer products marketer to re-launch the no!no! line of hair-removal products to retail and direct-to-consumer channels across Japan HORSHAM, Pa.--(BUSINESS WIRE)--Apr. 7, 2015-- PhotoMedex, Inc. (NASDAQ and TASE:PHMD) announces the signing of an exclusive distribution agreement by its Radiancy Inc. subsidiary with Synergy Trading Corporation for certain no!no!™ products in Japan. Synergy Trading Corporation, based in Osaka, has bee... 
03/16/15PhotoMedex Reports 2014 Fourth Quarter and Full Year Financial Results
HORSHAM, Pa.--(BUSINESS WIRE)--Mar. 16, 2015-- PhotoMedex, Inc. (NASDAQ and TASE: PHMD) today announced financial results for the three and 12 months ended December 31, 2014. Financial highlights of the fourth quarter of 2014 include the following (all comparisons are with the fourth quarter of 2013 and all figures quoted are GAAP, unless stated otherwise): Revenues of $38.9 million, a decrease of 39% Gr... 
02/02/15PhotoMedex Sells LCA-Vision Subsidiary to Vision Acquisition, LLC for $40 Million
HORSHAM, Pa.--(BUSINESS WIRE)--Feb. 2, 2015-- PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) (the “Company”) announces the sale of its LCA-Vision subsidiary to Vision Acquisition, LLC for $40 million in cash. Excluding working capital adjustments and professional fees, PhotoMedex will realize net proceeds of approximately $35.3 million. The Company’s secured creditors as well as its board of directors have approved this transaction, which closed effective as... 
11/06/14no!no!™ Hair Breaks Record on Home Shopping Television with the Most Units Sold on a Weekday
ORANGEBURG, N.Y.--(BUSINESS WIRE)--Nov. 6, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) announces that consumers purchased more than 24,000 no!no! Hair removal units on a U.S. live home shopping television broadcast during a 24-hour event on November 3, which was the most units the no!no! hair removal device has ever sold on such a weekday live TV home shopping 24-hour event, generating retail sales of approximately $4.8 million. The no!no! Hair ... 
11/06/14PhotoMedex Reports Third Quarter Financial Results
Conference call begins at 8:30 a.m. Eastern time today HORSHAM, Pa.--(BUSINESS WIRE)--Nov. 6, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE:PHMD) reports financial results for the three and nine months ended September 30, 2014. Financial highlights of the third quarter of 2014 include the following (all comparisons are with the third quarter of 2013 and all figures quoted are GAAP, unless stated otherwise): Revenues of $... 
11/04/14PhotoMedex Agrees to Amended Forbearance Agreement with Secured Creditors, Engages Canaccord Genuity to Evaluate Strategic Alternatives
HORSHAM, Pa.--(BUSINESS WIRE)--Nov. 4, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE:PHMD) announces the Company has entered into an Amended and Restated Forbearance Agreement (the "Amended Forbearance Agreement") with respect to its Credit Agreement dated May 12, 2014 and the Initial Forbearance Agreement dated August 25, 2014 by and among PhotoMedex, Inc. as borrower and the Lenders as parties thereto, and JPMorgan Chase Bank, N.A. (the "Administrative ... 
10/31/14PhotoMedex to Hold Third Quarter 2014 Conference Call on November 6th
HORSHAM, Pa.--(BUSINESS WIRE)--Oct. 31, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) will hold a conference call to discuss the Company’s third quarter 2014 financial results on Thursday, November 6, 2014 at 8:30 a.m. Eastern Time. A press release to announce those results will be issued on November 6th, prior to the opening of the U.S. stock market. To participate in the conference call, dial toll free 888-428-9473 or Interna... 
08/07/14New Independent Clinical Study of no!no! Hair Shows Substantial and Statistically Significant Reduction in Hair Regrowth on a Range of Skin Types and Hair Colors
HORSHAM, Pa.--(BUSINESS WIRE)--Aug. 7, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE:PHMD) today announced that a new independent clinical study demonstrated a substantial reduction in hair regrowth following use of no!no! Hair using proprietary Thermicon™ technology. PhotoMedex’s consumer products subsidiary Radiancy Inc. manufactures and sells the no!no! product line worldwide. The study was conducted by the Consumer Product Testing Company, a wor... 
08/07/14PhotoMedex Reports Second Quarter Financial Results
Conference call begins at 8:30 a.m. Eastern time today HORSHAM, Pa.--(BUSINESS WIRE)--Aug. 7, 2014-- PhotoMedex, Inc. (NasdaqGS:PHMD) (TASE:PHMD) reports financial results for the three and six months ended June 30, 2014. Financial highlights of the second quarter of 2014 include the following (all comparisons are with the second quarter of 2013 and all figures quoted are GAAP, unless stated otherwise): Revenues of $5... 
08/04/14PhotoMedex to Hold Second Quarter 2014 Conference Call on August 7th
HORSHAM, Pa.--(BUSINESS WIRE)--Aug. 4, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) will hold a conference call to discuss the Company’s second quarter 2014 financial results on Thursday, August 7, 2014 at 8:30 a.m. Eastern Time. A press release to announce those results will be issued on August 7th, prior to the opening of the U.S. stock market. To participate in the conference call, dial toll free 888-299-7209 or Internation... 
05/12/14PhotoMedex Reports First Quarter Financial Results, Announces LCA-Vison Stockholders Approve Acquisition
XTRAC Treatment Revenues up 72%, Adjusted Non-GAAP Diluted EPS of $0.23 Conference call at 11:00 a.m. Eastern time today HORSHAM, Pa.--(BUSINESS WIRE)--May 12, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE:PHMD) reports financial results for the three months ended March 31, 2014 and announces LCA-Vision stockholder approval of PhotoMedex’s previously announced acquisition of all outstanding shares of LCA-Vision, a leading provider of las... 
04/28/14PhotoMedex to Hold First Quarter 2014 Conference Call on May 12th
HORSHAM, Pa.--(BUSINESS WIRE)--Apr. 28, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) will hold a conference call to discuss the Company’s first quarter 2014 financial results on Monday, May 12, 2014 at 11:00 a.m. Eastern Time. A press release to announce those results will be issued on May 12th, prior to the opening of the U.S. stock market. To participate in the conference call, dial toll free 888-417-8516 or International/to... 
03/18/14PhotoMedex Announces no!no! Hair Breaks Sales Record on U.K. TV Home Shopping, and Launch of Neova in U.K. Premium Retail
HORSHAM, Pa.--(BUSINESS WIRE)--Mar. 18, 2014-- PhotoMedex, Inc. (NASDAQ and TASE: PHMD) announces that last Saturday no!no!™ Hair Pro3 broke another beauty sales record when consumers purchased more than 10,500 units for total retail sales exceeding £1.7 million ($2.8 million) in a 24-hour special event on the major television home shopping channel in the U.K. This special event marked the television home shopping launch of the newly revealed no!no! Hair Pro3 model. The no!no! hair removal pro... 
03/13/14PhotoMedex Reports Record Revenues for the 2013 Fourth Quarter and Full Year
Fourth quarter revenues up 16% over prior year, consumer revenues up 16%, XTRAC treatment revenues up 80% HORSHAM, Pa.--(BUSINESS WIRE)--Mar. 13, 2014-- PhotoMedex, Inc. (NASDAQ and TASE:PHMD) today announced financial results for the fourth quarter and full year ended December 31, 2013. Financial highlights include: Fourth Quarter 2013 (all comparisons are with the fourth quarter of 2012): Revenues of $63.5 million, an increase of 16% Gross profit of $50.8 million, an increase of 18% ... 
03/05/14PhotoMedex to Hold Fourth Quarter 2013 Conference Call on March 13th
HORSHAM, Pa.--(BUSINESS WIRE)--Mar. 5, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) will hold a conference call to discuss the Company's fourth quarter 2013 financial results on Thursday, March 13, 2014 at 11:00 a.m. Eastern Time. A press release to announce those results will be issued on March 13th, prior to the opening of the U.S. stock market. To participate in the conference call, dial toll free 877-397-0292 or International/toll 719-325-4750 (and confirmation code # 3316100) appro... 
03/04/14PhotoMedex Appoints Trevor S. Harris to Its Board of Directors
HORSHAM, Pa.--(BUSINESS WIRE)--Mar. 4, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) announces the appointment of Trevor S. Harris, Ph.D., CA (SA) to the Company's board of directors, returning the board’s size to eight members. Effective April 1, 2014, Dr. Harris will also serve as chairman of the Company’s audit committee. He replaces Dr. Nahum Melumad, who passed away on January 15, 2014. "We are pleased to announce the appointment ... 
02/19/14PhotoMedex to Present at 2014 RBC Capital Markets’ Healthcare Conference on February 26
HORSHAM, Pa.--(BUSINESS WIRE)--Feb. 19, 2014-- PhotoMedex, Inc. (NASDAQ and TASE: PHMD) today announced that Dennis McGrath, president and chief financial officer, will present at the 2014 RBC Capital Markets Healthcare Conference on Wednesday, February 26th at 11:30 a.m. Eastern time. The presentation will provide a corporate overview and a discussion of the Company's growth strategy. The conference will be held at the New York Palace Hotel in New York City. Management will be available for o... 
02/13/14PhotoMedex Signs Definitive Agreement to Acquire LCA-Vision for $5.37 per Share in Cash, or $106 Million
Combines a leading developer and marketer of skin health and wellness products to consumers and patients worldwide with a market-leading clinical service delivery platform utilizing direct-to-consumer customer acquisition model Expected to bring recurring, reimbursed revenue from the XTRAC® Excimer Laser for treating psoriasis and vitiligo and dispensing of the Neova® product line to underutilized LasikPlus® infrastructure and professional staff Expected to be accretive to PhotoMedex's cash ... 
02/07/14PhotoMedex to Present at the Leerink Global Healthcare Conference on February 13
HORSHAM, Pa.--(BUSINESS WIRE)--Feb. 7, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) today announced that Dennis McGrath, president and chief financial officer, will present at the Leerink Global Healthcare Conference on Thursday, February 13th at 11:35 a.m. Eastern time. The presentation will provide a corporate overview and a discussion of the Company's growth strategy. The conference will be held at The Waldorf Astoria Hotel in New York City. Management will be available for one-on-one ... 
01/29/14PhotoMedex Mourns the Death of Director Dr. Nahum Melumad
HORSHAM, Pa.--(BUSINESS WIRE)--Jan. 29, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) today announced that Nahum Melumad, Ph.D., age 58, a member of the Company's Board of Directors, passed away on January 15, 2014. Dr. Melumad joined the Board of PhotoMedex following its merger with Radiancy, Inc. in December 2011 and served as Chairman of its Audit Committee for the past two years. "We are deeply saddened by the death of our esteemed colleague," said Lewis C. Pell, Chairman of PhotoMedex... 
01/06/14PhotoMedex, Inc. to Present at the 16th Annual Needham Growth Conference
HORSHAM, Pa.--(BUSINESS WIRE)--Jan. 6, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE:PHMD) today announced that Dennis McGrath, president and chief financial officer, will present at the 16th Annual Needham Growth Conference on Wednesday, January 15th at 8:40 a.m. Eastern Time. The presentation will provide a corporate overview and a discussion of the Company's growth strategy. The conference will be held at The New York Palace Hotel, Fifth Avenue at Central Park South, New York, New York. Manage... 
01/02/14PhotoMedex Raises Fourth Quarter Revenue Guidance to More Than $60 Million; Expects to Set Quarterly and Annual Revenue Records
HORSHAM, Pa.--(BUSINESS WIRE)--Jan. 2, 2014-- PhotoMedex, Inc. (NASDAQ: PHMD) (TASE: PHMD) today announced that it expects revenues for the fourth quarter of 2013 to be more than $60 million without any contribution from Japan, compared with prior guidance issued on November 6, 2013 for revenues for the fourth quarter of 2013 to be more than $55 million without any expected contribution from Japan. The Company attributes the quarterly revenue outperformance to holiday advertising in the Consumer... 
Stock chart for: PHMD.O
PHMD (Common Stock)
Price$1.04
Change (%) Stock is Down 0.03 (0.00%)
Volume60,833
Data as of 08/04/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Transfer Agent
Broadridge
51 Mercedes Way
Edgewood, NY 11717
P: 877-830-4936
F: 215-553-5402
shareholder@broadridge.com

Contact IR
LHA, Inc.
Kim Sutton Golodetz (investors)
212-838-3777
Kgolodetz@lhai.com
Bruce Voss, 310-691-7100
Bvoss@lhai.com
@LHA_IR_PR

Data provided by Nasdaq. Minimum 15 minutes delayed.